Industry Strength Score
56/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
FRESH2 GROUP LIMITED (FRES) Stock Price & Overview
NASDAQ:FRES • US03635R3057
Current stock price
0.85 USD
-0.27 (-24.11%)
At close:
0.71 USD
-0.14 (-16.47%)
After Hours:
The current stock price of FRES is 0.85 USD. Today FRES is down by -24.11%. In the past month the price decreased by -35.11%. In the past year, price decreased by -90.45%.
FRES Key Statistics
52-Week Range0.7343 - 9
Current FRES stock price positioned within its 52-week range.
1-Month Range0.7343 - 1.51
Current FRES stock price positioned within its 1-month range.
- Market Cap
- 20.85M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
FRES Stock Performance
Today
-24.11%
1 Week
-38.41%
1 Month
-35.11%
3 Months
-37.50%
Longer-term
6 Months -74.44%
1 Year -90.45%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
FRES Stock Chart
FRES Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to FRES. When comparing the yearly performance of all stocks, FRES is a bad performer in the overall market: 98.36% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
FRES Earnings
Next Earnings DateN/A
Last Earnings DateNov 5, 2024
PeriodQ2 / 2023
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
FRES Forecast & Estimates
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
FRES Financial Highlights
Income Statements
Revenue(TTM)N/A
Net Income(TTM)-124.58M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
FRES Ownership
Ownership
Inst Owners0.21%
Shares24.53M
Float1.22M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
FRES Industry Overview
FRES operates in the Biotechnology sub-industry within the Health Care sector. This group contains 416 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
13/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
50%
Outperformed 50% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 416
- New Highs
- 5.1%
- New Lows
- 4.6%
- Average ROE
- 47%
- Average Profit Margin
- 20.7%
- Average Operating Margin
- 33.8%
- Average P/E
- 22.9
- Average Fwd P/E
- 18.3
- Average Debt/Equity
- 2.1
FRES Competitors/Peers
The largest stocks on the US markets in the "Biotechnology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 12.59 | 365.426B | ||
| AMGN | AMGEN INC | 13.88 | 178.001B | ||
| GILD | GILEAD SCIENCES INC | 14.89 | 163.407B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 21.77 | 107.828B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 74.154B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 27.54 | 39.51B | ||
| NTRA | NATERA INC | N/A | 29.378B | ||
| INSM | INSMED INC | N/A | 28.764B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 27.641B | ||
| BIIB | BIOGEN INC | 11.44 | 27.453B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.52 | 25.001B | ||
| INCY | INCYTE CORP | 10.61 | 19.286B | ||
| MRNA | MODERNA INC | N/A | 17.993B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FRES
Company Profile
Fresh2 Group Ltd is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 75 full-time employees. The company went IPO on 2020-01-30. Fresh2 Group Limited is engaged in the business-to-business e-commerce and supply chain sectors. The firm employs an advanced supply chain management system, establishing direct connections with suppliers worldwide. By eliminating intermediaries and facilitating direct supplier-to-restaurant interactions, the Company creates a platform that offers new avenues of discovery and more pricing options for both restaurants and suppliers. Its business operations are built around an advanced e-commerce platform that connects food suppliers and supermarket operators and restaurant owners in the United States. Its platform includes mobile applications and a Website, providing clients with convenient access to a range of Asian food and foodservice products and ingredients. The firm offers various choices of products and find restaurant suppliers, such as disposable, dry goods, beverage, janitorial, equipment, meat, vegetables, seafood, dairy, and more.
Company Info
IPO: 2020-01-30
FRESH2 GROUP LIMITED
880 3Rd Ave,Floor 7
New York City NEW YORK US
Employees: 75
Phone: 19173976890
FRESH2 GROUP LIMITED / FRES FAQ
What does FRES do?
Fresh2 Group Ltd is a US-based company operating in Biotechnology industry. The company is headquartered in New York City, New York and currently employs 75 full-time employees. The company went IPO on 2020-01-30. Fresh2 Group Limited is engaged in the business-to-business e-commerce and supply chain sectors. The firm employs an advanced supply chain management system, establishing direct connections with suppliers worldwide. By eliminating intermediaries and facilitating direct supplier-to-restaurant interactions, the Company creates a platform that offers new avenues of discovery and more pricing options for both restaurants and suppliers. Its business operations are built around an advanced e-commerce platform that connects food suppliers and supermarket operators and restaurant owners in the United States. Its platform includes mobile applications and a Website, providing clients with convenient access to a range of Asian food and foodservice products and ingredients. The firm offers various choices of products and find restaurant suppliers, such as disposable, dry goods, beverage, janitorial, equipment, meat, vegetables, seafood, dairy, and more.
What is the stock price of FRESH2 GROUP LIMITED today?
The current stock price of FRES is 0.85 USD. The price decreased by -24.11% in the last trading session.
What is the dividend status of FRESH2 GROUP LIMITED?
FRES does not pay a dividend.
How is the ChartMill rating for FRESH2 GROUP LIMITED?
FRES has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.